however , because of high oxygen affinity ( p50 approximately 14 mm hg ) and short vascular retention time of hemoglobin ( plasma half-disappearance time approximately 3.5 hr ) , a solution of hemoglobin presents limitations for its general use in blood replacement therapy .
C0019046
hemoglobin
C0019016
a